M.D. Anderson Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 3,044 studies whose lead sponsor is M.D. Anderson Cancer Center. 578 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the M.D. Anderson Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions M.D. Anderson Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Leukemia302Neoplasms278Breast Neoplasms201Lymphoma172Leukemia, Myeloid, Acute161Lung Neoplasms149Myelodysplastic Syndromes148Prostatic Neoplasms116Carcinoma112Melanoma98Leukemia, Lymphocytic, Chronic, B-Cell90Colorectal Neoplasms89Carcinoma, Non-Small-Cell Lung83Hematologic Neoplasms80Neoplasm Metastasis79Brain Neoplasms77Precursor Cell Lymphoblastic Leukemia-Lymphoma73Leukemia, Myelogenous, Chronic, BCR-ABL Positive69Ovarian Neoplasms68Multiple Myeloma65Head and Neck Neoplasms63Pancreatic Neoplasms61Carcinoma, Renal Cell54Uterine Cervical Neoplasms51
Show all 95 areas
Sarcoma48Leukemia, Myelomonocytic, Chronic42Glioblastoma41Adenocarcinoma39Endometrial Neoplasms37Lymphoma, Non-Hodgkin36Lymphoma, Mantle-Cell35Carcinoma, Squamous Cell33Carcinoma, Hepatocellular32Hodgkin Disease31Urinary Bladder Neoplasms30Esophageal Neoplasms29Lymphoma, B-Cell29Squamous Cell Carcinoma of Head and Neck29Fallopian Tube Neoplasms28Primary Myelofibrosis28Fatigue27Carcinoma, Ovarian Epithelial26Gastrointestinal Neoplasms25Glioma25Kidney Neoplasms25Myeloproliferative Disorders25Lymphoma, T-Cell23Oropharyngeal Neoplasms22Triple Negative Breast Neoplasms22Colonic Neoplasms21Mouth Neoplasms21Blast Crisis20Carcinoma, Transitional Cell20Liver Neoplasms20Burkitt Lymphoma19Inflammatory Breast Neoplasms18Lymphoma, Follicular18Lymphoma, Large B-Cell, Diffuse18Rectal Neoplasms18Thyroid Neoplasms18Leukemia, Myeloid, Chronic-Phase17Leukemia, Myelomonocytic, Juvenile17Central Nervous System Neoplasms15COVID-1915Graft vs Host Disease15Leukemia, Biphenotypic, Acute15Skin Neoplasms15Infections14Stomach Neoplasms14Gliosarcoma13Peripheral Nervous System Diseases13Uterine Neoplasms13Vomiting13Depression12Fever12Leukemia, Myeloid, Accelerated Phase12Nausea12Neuroendocrine Tumors12Peritoneal Neoplasms12Bone Neoplasms11Cholangiocarcinoma11Genital Neoplasms, Female11Hyperthermia11Osteosarcoma11Polycythemia Vera11Uterine Cervical Dysplasia11Vaginal Neoplasms11Communicable Diseases10Dyspnea10Hematologic Diseases10Lymphoma, T-Cell, Peripheral10Mesothelioma, Malignant10Mycosis Fungoides10Myelodysplastic-Myeloproliferative Diseases10Urologic Neoplasms10
Studies
Recruiting first, then most recently updated. Showing 50 of 3,044. Browse all 3,044 →
- Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma PatientsRecruitingNCT05776979Phase 2
- Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an AmputationRecruitingNCT06840262Not applicable
- PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyRecruitingNCT07874828Phase 2
- Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate CancerRecruitingNCT05873192Phase 2
- Combination Therapy for Cancer Related Fatigue in Patients With Metastatic CancersRecruitingNCT06085716Phase 2/3
- Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)RecruitingNCT07089953Not applicable
- A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in MDS/AML With TP53 MutationsRecruitingNCT07646821Phase 1/2
- Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot StudyNot yet recruitingNCT07257068Not applicable
- Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image RegistrationNot yet recruitingNCT07877220Not applicable
- Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyRecruitingNCT05287451Not applicable
- Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing ScreeningRecruitingNCT07513116Not applicable
- ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal CancerRecruitingNCT07318389Early Phase 1
- Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid CancerNot yet recruitingNCT07470489Phase 2
- Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking TamoxifenRecruitingNCT05056857
- PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT02390635Phase 1
- Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.RecruitingNCT06722846
- Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.RecruitingNCT06236724Phase 2
- Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid LeukemiaRecruitingNCT06629584Phase 2
- Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaRecruitingNCT06308588Phase 1/2
- Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung CancerRecruitingNCT07415005Phase 2
- Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLNot yet recruitingNCT07604233Phase 1/2
- Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseRecruitingNCT07269470Phase 2
- Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMSRecruitingNCT07076186Phase 2
- Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade GliomasRecruitingNCT07649070Phase 2
- Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyNot yet recruitingNCT07871760
- Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And Acceptability Of A Remotely-Delivered Meal Kit And Culinary Medicine Program For Survivors Of Adolescent/Young Adult (AYA) CancerNot yet recruitingNCT07871773Not applicable
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerRecruitingNCT02918474Not applicable
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruitingNCT00539162Not applicable
- Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans SyndromeRecruitingNCT04604522
- Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in RemissionRecruitingNCT05010772Phase 1
- A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)RecruitingNCT06616636Phase 1
- Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt RegistryRecruitingNCT06840288
- Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)RecruitingNCT07128381Phase 1/2
- Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationRecruitingNCT07076498Phase 1
- Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07564232Phase 1
- Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingNCT00501826Phase 2
- A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)RecruitingNCT07508995Phase 2
- Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The PeritoneumRecruitingNCT07509008Phase 1/2
- A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic CholangiocarcinomaRecruitingNCT05967182Phase 2
- Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain MetastasesRecruitingNCT05064280Phase 2
- Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base TumorsRecruitingNCT05733091
- Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT00801489Phase 2
- Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicRecruitingNCT04474301
- Molecular Basis for Variations in Hereditary Colorectal Cancer SyndromesRecruitingNCT02863172
- Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaRecruitingNCT06053658Phase 2
- Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingRecruitingNCT05497024
- Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingRecruitingNCT05126810
- Spanish Decision Tool for Ovarian Cancer Maintenance TherapyRecruitingNCT06036810Not applicable
- Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH StudyRecruitingNCT04783168Not applicable
- Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryRecruitingNCT04003038Not applicable